Yufang Bi
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 54
- Diet, Metabolism, and Disease 21
- Nephrology top 1%
-
- Cardiovascular Health and Disease Prevention 26
- Blood Pressure and Hypertension Studies 24
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment 62
-
- Genetic Associations and Epidemiology 28
-
- Nutritional Studies and Diet 19
-
- Birth, Development, and Health 17
- Journals
- The Lancet (3 papers)Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yufang Bi
272 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Endocrinology, Diabetes and Metabolism 1.8k
- Health, Toxicology and Mutagenesis 916
- Nephrology 402
- Cardiology and Cardiovascular Medicine 1.3k
- Epidemiology 1.8k
Countries citing papers authored by Yufang Bi
This map shows the geographic impact of Yufang Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufang Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufang Bi more than expected).
Fields of papers citing papers by Yufang Bi
This network shows the impact of papers produced by Yufang Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufang Bi. The network helps show where Yufang Bi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yufang Bi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 13 | |
| 11 | 2023 | 14 | |
| 12 | 2023 | 8 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2022 | 10 | |
| 17 | 2022 | 7 | |
| 18 | 2022 | 48 | |
| 19 | 2021 | 10 | |
| 20 | 2021 | 84 |
About Yufang Bi
Yufang Bi is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Nephrology, having authored 286 papers that have together received 6.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (62 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (54 papers), Genetic Associations and Epidemiology (28 papers), Cardiovascular Health and Disease Prevention (26 papers), Blood Pressure and Hypertension Studies (24 papers), Diet, Metabolism, and Disease (21 papers), Nutritional Studies and Diet (19 papers) and Birth, Development, and Health (17 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.8k citations), Health, Toxicology and Mutagenesis (916 citations) and Nephrology (402 citations). Yufang Bi has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Guang Ning, Min Xu, Weiqing Wang, Yu Xu, Jieli Lu, Tiange Wang, Yuhong Chen, Mian Li, Zhiyun Zhao and Baihui Xu. Their work appears in journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.